MarginsXMarginsX
Home › Markets › DBVTF

DBV Technologies S.A. (DBVTF)

DBVTF is quoted over the counter, not listed on an exchange. DBV Technologies S.A. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · November 9, 2026
$2.21
No trades since Nov 9, 2026; later closes repeat the last quote
1-year return
+2209900.0%
Market cap
The company also trades on Nasdaq as DBVT; this OTC line is another class or a foreign line, so its cap is not computed
P/E and P/S
Needs a market cap · Needs a market cap
On trailing twelve months to September 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerDBVTF, quoted over the counter
SEC CIK0001613780
OTC Markets tierPink (price source, 2026-11-13)
SEC industry codeBiological Products, (No Diagnostic Substances)
Business addressChatillon
Incorporated inFrance

Warning signs

Cash runway
10.6 months
$165.7M cash at September 30, 2026
Share count, 1 year
+85.9%
2025-10-27 to 2026-10-26 · +553.0% over 3 years
Going-concern doubt
Yes
10-Q filed October 28, 2026
Insider net buying, 12 months
-$15.5M
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Accordingly, substantial doubt exists about the Company's ability to continue as a going concern within twelve months after the date these condensed consolidated financial statements are issued."
10-Q 2026-10-28
Cash and burn$165.7M cash; operating cash flow -$47.1M a quarter.Report 2026-09-30
Shares outstanding62,877,761 (2026-10-26); 33,822,724 a year earlier; 19,257,711 three years earlier. 3y figure adjusted for split (1-for-2 overall).Cover page 2026-10-26
Reverse splits, 3 years1; latest 1-for-2 on 2024-06-07Source 2024-06-07
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-07-27
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Associés, Paris-La Défense, FrancePCAOB Form AP 2026-04-29
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $15.5M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$1.6M-$64.5M-$51.5M$165.7M$200K$3.8M10-Q 2026-10-28
Q2 2026
2026-06-30
$700K-$50.4M-$52.6M$174.9MNo debt tags$5.0M10-Q 2026-07-16
Q1 2026
2026-03-31
$900K-$47.6M-$49.1M$229.2MNo debt tags$5.8M10-Q 2026-04-30
Q4 2025
2025-12-31
$636K-$44.8M-$35.2M$194.2M$0$5.7M10-K 2026-03-26
Q3 2025
2025-09-30
$2.8M-$33.2M-$32.4M$69.8MNo debt tags$5.6M10-Q 2026-10-28
Q2 2025
2025-06-30
$1.5M-$41.9M-$33.9M$103.2MNo debt tags$3.9M10-Q 2026-07-16
Q1 2025
2025-03-31
$800K-$27.1M-$19.7M$13.0MNo debt tags$3.5M10-Q 2026-04-30
Q4 2024
2024-12-31
$511K-$23.0M-$12.3M$32.5MNo debt tags$4.2M10-K 2026-03-26

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2026-07-27
Latest annual report10-K/A2026-04-30
Latest quarterly / interim10-Q2026-10-28
Latest current report8-K2026-10-28
Latest proxyDEF 14A2026-05-11

Source: SEC EDGAR submissions feed, 578 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier